Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About AllianceBernstein Holding LP (AB) Anymore

Page 1 of 2

At the moment, there are dozens of metrics investors can use to analyze the equity markets. A pair of the best are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite investment managers can outperform their index-focused peers by a superb margin (see just how much).

AllianceBernstein Holding LP (NYSE:AB)

Just as key, optimistic insider trading activity is another way to analyze the world of equities. As the old adage goes: there are lots of reasons for an upper level exec to drop shares of his or her company, but only one, very clear reason why they would initiate a purchase. Various academic studies have demonstrated the valuable potential of this method if piggybackers know what to do (learn more here).

Thus, we’re going to analyze the newest info surrounding AllianceBernstein Holding LP (NYSE:AB).

How are hedge funds trading AllianceBernstein Holding LP (NYSE:AB)?

At Q2’s end, a total of 9 of the hedge funds we track were long in this stock, a change of -10% from the first quarter. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were boosting their stakes substantially.

Out of the hedge funds we follow, Royce & Associates, managed by Chuck Royce, holds the most valuable position in AllianceBernstein Holding LP (NYSE:AB). Royce & Associates has a $85.1 million position in the stock, comprising 0.3% of its 13F portfolio. Coming in second is GAMCO Investors, managed by Mario Gabelli, which held a $11.8 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include Jim Simons’s Renaissance Technologies, John A. Levin’s Levin Capital Strategies and Charles Davidson’s Wexford Capital.

Because AllianceBernstein Holding LP (NYSE:AB) has faced declining interest from the entirety of the hedge funds we track, it’s easy to see that there were a few money managers who were dropping their positions entirely heading into Q2. At the top of the heap, Steven Owsley’s Madison Street Partners cut the biggest stake of the 450+ funds we track, worth about $0.4 million in stock. Bill Miller’s fund, Legg Mason Capital Management, also sold off its stock, about $0.1 million worth. These transactions are important to note, as total hedge fund interest dropped by 1 funds heading into Q2.

How are insiders trading AllianceBernstein Holding LP (NYSE:AB)?

Legal insider trading, particularly when it’s bullish, is at its handiest when the company in question has experienced transactions within the past six months. Over the last half-year time period, AllianceBernstein Holding LP (NYSE:AB) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to AllianceBernstein Holding LP (NYSE:AB). These stocks are Cohen & Steers, Inc. (NYSE:CNS), Financial Engines Inc (NASDAQ:FNGN), Fortress Investment Group LLC (NYSE:FIG), Janus Capital Group Inc (NYSE:JNS), and Federated Investors Inc (NYSE:FII). This group of stocks are in the asset management industry and their market caps are closest to AB’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!